Thulium vs. Hol:YAG Laser
Nephrolithiasis
About this trial
This is an interventional treatment trial for Nephrolithiasis
Eligibility Criteria
Inclusion criteria: Undergoing single stage unilateral RIRS for total stone burden volume >5mm to < 20 mm Preoperative CT scan for baseline measurements Exclusion criteria: Anatomic variations: horseshoe kidney, pelvic kidney, ptotic kidney, urinary diversion or ureteral stricture Ureteral stent Uric acid component >50% on stone analysis Prior ureteroscopy within 6 weeks of current surgery Irreversible coagulopathy Urothelial tumor(s), direct extraction of the stone(s) without needing laser lithotripsy, and failure to reach the stone in the upper urinary tract with the ureteroscope.
Sites / Locations
- Mount Sinai WestRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Thulium Fibre Laser (TFL)
Holmium:Yttrium-Aluminum-Garnet (Ho:YAG)
Patients who are randomized to undergo ureteroscopic laser lithotripsy with the Thulium fibre laser (TFL)
Patients who are randomized to undergo ureteroscopic laser lithotripsy with the Holmium:Yttrium-Aluminum-Garnet (Ho:YAG) laser